Before choosing a Gimme Care plan, ask for three things in writing: the exact medication and dispensing pharmacy, the amount charged at checkout and renewal, and the point at which an order becomes noncancelable. Those questions connect the company’s appealing monthly prices with the practical responsibilities of receiving prescription treatment. Gimme describes an online weight-management service offering compounded semaglutide and tirzepatide, with clinician review, supplies, shipping and support bundled into its advertised plans.
This documentary review examines public pages consulted October 19, 2026, rather than a purchased treatment experience. Gimme’s materials explain much of the intended process, including questionnaires, portal messaging, recurring shipments and a conditional four-month satisfaction policy. They do not establish every operational detail a patient might need. The goal is to separate documented answers from questions worth resolving before enrollment—not to decide which medicine, if any, is appropriate for an individual.
At a glance
- Who provides care
- Start Gimme, LLC operates the site. The terms identify Bask Telehealth LLC as the telehealth channel; Gimme says it does not directly provide medical services and is not a pharmacy.
- Advertised semaglutide pricing
- Compounded subcutaneous semaglutide is listed at $160 per month for a one-month cycle, $130 per month for three months and $119 per month for six months. The homepage says the $130 plan is billed every three months.
- Advertised tirzepatide pricing
- Compounded subcutaneous tirzepatide is listed at $199 per month for a one-month cycle, $163 per month for three months and $149 per month for six months. The product block does not specify total upfront collection.Sources: [6]
- Coverage and payment
- Gimme advertises all 50 states and Washington, D.C. Its terms describe cash-pay services outside commercial insurance, Medicare and Medicaid, not insurance billing.
Who will actually be responsible for your care?
Gimme Care is the storefront, but its terms describe separate organizations behind the service. Start Gimme, LLC and its affiliates operate the website. Medical services come through a contracted network of healthcare providers whom the company says are licensed in the patient’s state. The terms identify Bask Telehealth LLC as the channel through which a provider delivers telehealth services. These are provider statements, not independently verified licensing findings.
Gimme also explicitly says it is not a pharmacy. That distinction makes a practical question especially important: who should you contact about a prescription decision, a dispensing problem or a charge? Ask for the treating clinician’s name and professional credential, the dispensing pharmacy’s identity and a clear escalation route. The consulted documentation does not name the pharmacies, establish their locations or verify which pharmacy handles each treatment.
The terms give Bask a mailing address at 555 Madison Ave., Suite 1202, New York, NY 10022. They also reference email contact, but the consulted text does not expose a usable email address. Before paying, confirm working contact details rather than relying on a masked address. Our guide to what a program should explain before enrollment can help organize these responsibilities without treating the platform, clinician and pharmacy as interchangeable.
What are you being offered—not just which ingredient?
The two weight-management product pages describe compounded semaglutide and compounded tirzepatide as once-weekly subcutaneous injections. They do not confirm an oral or sublingual version. Gimme says its compounded GLP-1 products come exclusively from U.S. pharmacies and acknowledges that these preparations are not FDA approved. Its footer further states that its formulations have not undergone clinical trials evaluating safety, efficacy or therapeutic equivalence to FDA-approved medicines.
Those disclosures should lead to specific product questions, not assumptions about equivalence. The consulted materials do not establish the added ingredients, concentration, actual container presentation, quantity supplied per shipment or storage requirements. Ask for the prescription’s complete formulation and pharmacy instructions before comparing offers. The medication questions guide explains why an ingredient name alone cannot resolve those differences. Nothing in this documentation establishes that Gimme uses semaglutide salts.
FDA recommends compounded drugs when an individual’s medical needs cannot be met by an FDA-approved drug, with a prescription and a state-licensed pharmacy. Compounded preparations do not receive FDA premarket review for safety, effectiveness and quality; that absence alone does not prove clinical inequivalence. Gimme also markets sermorelin, NAD+, B12, MIC+B12 and glutathione products. Their presence on the storefront does not establish that they are included in a GLP-1 plan or appropriate additions for a particular patient.
What happens between the questionnaire and a prescription?
Gimme’s advertised process begins with an online questionnaire about health and goals. A licensed healthcare professional reviews that information and prescribes only if medically appropriate. This is an access pathway, not a promise of approval. The consulted pages do not specify operational BMI thresholds, required comorbidities, a complete exclusion list or mandatory laboratory testing. Ask what records and tests the reviewing clinician needs, and whether any outside testing creates a separate cost.
The homepage advertises service in all 50 states and Washington, D.C., but that does not guarantee every patient access to every product. In most states, Gimme says treatment can begin without a video visit and that patients may request one through the portal. It identifies Kansas, Louisiana, Mississippi, New Mexico and West Virginia as requiring a brief video or audio visit before treatment begins. Confirm the process that applies to your location.
The terms describe an intended audience age 18 or older and say some services may require patients to be over 21. The same age provision contains a parental-consent clause for access that violates the age requirement; it should not be read as confirmation of clinical eligibility for minors. For adults, the more useful consultation question is how the clinician evaluates medical history, other medicines, allergies and pregnancy plans, rather than whether completing the form is enough.
What amount will actually leave your account?
Gimme publishes concrete prices, so the question is not simply whether pricing is available. It is how the displayed monthly rate becomes a charge. Semaglutide is advertised at $160, $130 or $119 per month across one-, three- and six-month cycles. Tirzepatide is $199, $163 or $149, respectively. The homepage explicitly says its $130 monthly three-month plan is billed every three months; that answer does not name the drug, although the figures match semaglutide.
The product blocks do not fully explain total upfront collection or prepayment conditions for every longer plan. Do not assume either mandatory prepayment or monthly installments from the monthly display alone. Ask for the first charge, subsequent charge, renewal date and treatment of unused balances. A six-month package label also does not establish the quantity in each shipment or, by itself, a minimum contractual commitment. The price questions checklist helps separate those issues.
Gimme’s tirzepatide page says consultation, care, medication, supplies, shipping and support are included, with the same price at every dose and no membership or hidden fees. Its general pricing answer makes similar bundled claims. Laboratory tests and external services are not clearly addressed. The terms also go beyond “no insurance required”: Gimme and its providers do not accept commercial insurance, are not in-network and are not enrolled in Medicare or Medicaid. This is documented as cash-pay care.
| Compounded subcutaneous product | Advertised monthly rate | Clarify before checkout |
|---|---|---|
| Semaglutide, one-month cycle | $160 per month | Exact first charge and renewal date |
| Semaglutide, three-month cycle | $130 per month | Homepage says billed every three months; confirm checkout amount |
| Semaglutide, six-month cycle | $119 per month | Total collection and unused-balance rules are not established |
| Tirzepatide, one-month cycle | $199 per month | Confirm recurring charge and included services |
| Tirzepatide, three- or six-month cycle | $163 or $149 per month, respectively | Confirm upfront collection, renewal and cancellation terms |
Who answers after the first prescription?
Gimme advertises unlimited provider messaging for follow-ups, adjustments and questions. Its online portal also supports customer-support chat, weight tracking, refill management and shipment updates. These are meaningful service features because they provide an intended route back to the care team. However, unlimited message access does not establish an immediate reply, a scheduled clinical reassessment or continuous clinician staffing. Ask how medical messages are prioritized and what response window the service actually uses.
The homepage’s broad availability language needs to be read alongside the refund policy, which lists support hours of 8 a.m. to 8 p.m. Eastern. Clarify whether those hours apply to administrative support, clinical responses or both, and what to do outside them. The documentation also does not confirm Spanish-language clinical care, interpretation or Spanish patient materials. If language access matters, obtain a direct answer before relying on the online process.
Privacy is another useful distinction between contact methods. Gimme’s terms warn that ordinary text messages and emails are not encrypted and could be intercepted. Ask which channel the service wants patients to use for sensitive documents and medical questions. Follow-up should address treatment response and tolerability, not just the next payment or refill. NIDDK describes medication decisions as involving benefits, side effects, health conditions, other medicines and costs—topics that deserve a clinician’s attention.
What happens if a shipment is late, damaged or warm?
Gimme says refills are shipped every 28 days after a short check-in, with tracking through the portal. That is a dispatch interval, not a promised arrival date, and 28 days is not a calendar month. The site also advertises discreet, free, guaranteed home delivery without a pharmacy visit, but does not give a general numeric delivery deadline. Ask how refill check-ins, billing dates and dispatch dates fit together, especially before travel or an address change.
The refund policy gives a specific deadline for damaged or defective medication: report it within 48 hours of delivery and provide photographs of the medication and original packaging. If the problem is confirmed, Gimme offers a replacement at no additional cost; a refund is available only if replacement is impossible. For a confirmed wrong medication or incorrect order, it says it will send the correct medication without an additional charge and provide return instructions if needed.
The consulted pages do not establish Gimme’s cold-chain specifications or a specific warm-delivery procedure. FDA explicitly advises not using an injectable GLP-1 drug that arrives warm or with insufficient refrigeration and contacting the provider or dispensing pharmacy. That clinical instruction is separate from Gimme’s commercial reporting deadline. Keep the packaging and confirm the correct reporting channel promptly. Our delivery questions guide can help prepare for a shipment problem before one occurs.
Can you stop future charges—and cancel the current order?
Gimme’s policy makes subscriptions the default unless checkout states otherwise. Any one-time purchase is supposed to be clearly identified there. Subscription details and cancellation options are available in the patient portal, but stopping future subscription activity and canceling an existing medication order are different questions. The principal order rule allows cancellation before the pharmacy dispenses or ships it. Once either event occurs, the order cannot be canceled.
Other policy passages refer only to cancellation before shipping, so obtain clarification about an order already dispensed but not yet shipped. The policy asks patients to email immediately and says a successfully canceled pre-shipment order receives a full refund within five to ten business days. It also states that prescription medications cannot be returned after dispensing or shipping and that medication sales are final. Canceling a subscription should therefore not be treated as an automatic refund request.
For other refund reviews, Gimme asks for an order number, purchase date and explanation, with supporting documentation potentially required. These refunds are not guaranteed. Requests are reviewed within five to seven business days; approved refunds are issued to the original payment method within another five to ten business days after approval. Issuance is not a guarantee of bank posting by that date. Longer-plan balances, price changes and complete renewal terms remain questions to resolve before enrollment.
What does the four-month Progress Promise really require?
The Gimme Progress Promise is separate from the general refund policy. To qualify, a person must be a first-time program member, remain enrolled for four consecutive months after the initial prescription, follow the clinician’s medication instructions and keep the account in good standing. It is not an unconditional trial period. The terms explicitly describe it as a customer satisfaction policy—not insurance, a medical warranty or a guarantee of a particular health or weight-loss result.
The documentation requirements begin early. Within 14 days of the first prescription, the member must submit a continuous, unedited baseline video showing them on a scale placed on a hard surface, with a visible reading, appropriate clothing and verbal confirmation of name and date. A claim for lack of measurable progress must then be submitted within 14 days after the four-month mark. The consulted passages do not define a uniform numerical threshold for “measurable progress.”
If approved, Gimme says it may refund the amount paid during the first four months, with full refunds in most approved cases. Decisions consider participation and incurred costs, so the language remains discretionary. Approved refunds are issued, whenever possible, to the original payment method within 30 days of approval—not necessarily received at the bank then. Members who have already initiated a chargeback or payment dispute cannot receive an additional refund under this policy.
Questions & answers
Does Gimme Care guarantee that I will receive a prescription?
No. Gimme says a licensed healthcare professional reviews the medical questionnaire and prescribes only when medically appropriate. Its advertised nationwide availability does not establish individual eligibility. Ask what happens financially if the clinician declines treatment, because the consulted documentation does not clearly settle that specific situation.
Is the $130 monthly price available for tirzepatide?
The documented $130 monthly rate corresponds to semaglutide’s three-month plan, and the homepage says that plan is billed every three months. Tirzepatide’s three-month rate is $163 per month. Its other advertised rates are $199 for the one-month cycle and $149 for the six-month cycle. Confirm the actual checkout charge rather than transferring semaglutide pricing to tirzepatide.
Can Gimme bill my commercial insurance or Medicare?
Its terms say Gimme and its providers do not accept commercial insurance, are not in-network and are not enrolled in Medicare or Medicaid. The service is described as cash-pay outside those programs. That is more restrictive than a marketing statement that insurance is unnecessary; do not budget on the assumption that Gimme will submit an insurance claim.
Can I speak with a clinician instead of relying only on a form?
Gimme says patients can request a video visit through the portal. It also identifies five states requiring a brief video or audio visit before starting: Kansas, Louisiana, Mississippi, New Mexico and West Virginia. Unlimited provider messaging is advertised for follow-up. Confirm scheduling, response times and whether your requested interaction falls within the advertised included care.
Does free shipping mean my refill will arrive every 28 days?
No. Gimme describes shipments being dispatched every 28 days after a short check-in, not delivery arriving on that schedule. Free shipping concerns the delivery charge, not transit speed or free treatment. The consulted materials do not establish a general numeric arrival deadline, so ask about tracking, delays and who handles a missed shipment.
Is the Progress Promise an automatic refund after four months?
No. It requires first-time membership, four consecutive months of enrollment, adherence to clinician instructions, an account in good standing and timely baseline-video documentation. The claim window is also limited. Even an eligible claim is reviewed under discretionary language; the policy is not a guarantee of a specific result or an unconditional return of every payment.
Our assessment
Gimme Care documents a recognizable online care pathway and publishes useful product-specific prices, bundled-service claims, state consultation differences and detailed delivery-problem rules. Its portal and advertised provider messaging offer a defined route for ongoing contact. The most consequential unanswered questions concern the dispensing pharmacy, exact formulation and shipment quantity, longer-plan collection and renewal terms, and clinical response times. Before enrolling, obtain those answers alongside a working contact address and a written explanation of how subscription cancellation differs from canceling a medication order. The Progress Promise deserves attention to its early documentation requirements, not reliance on its headline alone. These documents support practical comparison, but they do not independently establish pharmacy credentials, provider-specific clinical outcomes or the suitability of treatment for an individual.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Gimme Care — policies/terms of service ↗
- Gimme Care — official website ↗
- Gimme Care — policies/refund policy ↗
- Gimme Care — treatments/compounded tirzepatide ↗
- Gimme Care — treatments/compounded semaglutide ↗